LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus
NCT00349986
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class
Stopped
prematurely terminated due to loss of interest
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Insuline glargine
Sponsor
Sanofi